172 related articles for article (PubMed ID: 28410666)
1. A new CysLT
Sekioka T; Kadode M; Osakada N; Fujita M; Matsumura N; Yamaura Y; Nakade S; Nabe T; Kawabata K
Prostaglandins Leukot Essent Fatty Acids; 2017 Apr; 119():18-24. PubMed ID: 28410666
[TBL] [Abstract][Full Text] [Related]
2. Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; inoue A; Nakao T; Nomura H; Murata M; Nakao S; Nambu F; Fujita M; Nakade S; Kawabata K
Eur J Pharmacol; 2015 Oct; 765():242-8. PubMed ID: 26318198
[TBL] [Abstract][Full Text] [Related]
3. CysLT
Sekioka T; Kadode M; Yonetomi Y; Kamiya A; Fujita M; Nabe T; Kawabata K
Eur J Pharmacol; 2017 Jan; 794():147-153. PubMed ID: 27887950
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
5. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
6. Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction.
Sekioka T; Kadode M; Fujii M; Kawabata K; Abe T; Horiba M; Kohno S; Nabe T
Allergol Int; 2015 Oct; 64(4):351-8. PubMed ID: 26433531
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.
Itadani S; Yashiro K; Aratani Y; Sekiguchi T; Kinoshita A; Moriguchi H; Ohta N; Takahashi S; Ishida A; Tajima Y; Hisaichi K; Ima M; Ueda J; Egashira H; Sekioka T; Kadode M; Yonetomi Y; Nakao T; Inoue A; Nomura H; Kitamine T; Fujita M; Nabe T; Yamaura Y; Matsumura N; Imagawa A; Nakayama Y; Takeuchi J; Ohmoto K
J Med Chem; 2015 Aug; 58(15):6093-113. PubMed ID: 26200813
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cysteinyl leukotriene receptors on human saphenous veins: antagonist activity of montelukast and its metabolites.
Mechiche H; Candenas L; Pinto FM; Nazeyrollas P; Clément C; Devillier P
J Cardiovasc Pharmacol; 2004 Jan; 43(1):113-20. PubMed ID: 14668576
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotriene receptors.
Evans JF
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():587-97. PubMed ID: 12432945
[TBL] [Abstract][Full Text] [Related]
10. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
[TBL] [Abstract][Full Text] [Related]
11. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum.
Bäck M; Jonsson EW; Dahlén SE
Eur J Pharmacol; 1996 Dec; 317(1):107-13. PubMed ID: 8982726
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of CysLT
Matsuda M; Tabuchi Y; Nishimura K; Nakamura Y; Sekioka T; Kadode M; Kawabata K; Nabe T
Prostaglandins Leukot Essent Fatty Acids; 2018 Apr; 131():24-31. PubMed ID: 29628047
[TBL] [Abstract][Full Text] [Related]
14. [Leukotriene D4 activates BV2 microglia in vitro].
Zhang Z; Luo J; Huang J; Liu Z; Fang S; Zhang WP; Wei E; Lu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):253-60. PubMed ID: 23801612
[TBL] [Abstract][Full Text] [Related]
15. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
16. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings.
Xu L; Zhang L; Liu L; Fang S; Lu Y; Wei E; Zhang W
Pharmazie; 2010 Oct; 65(10):750-4. PubMed ID: 21105577
[TBL] [Abstract][Full Text] [Related]
17. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
Liu YC; Khawaja AM; Rogers DF
Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
[TBL] [Abstract][Full Text] [Related]
18. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene-induced contraction is mediated by cysteinyl leukotriene receptor CysLT1 in guinea pig fundus but by CysLT1 and CysLT2 in antrum.
Huang SC
Life Sci; 2011 Apr; 88(17-18):819-24. PubMed ID: 21396378
[TBL] [Abstract][Full Text] [Related]
20. Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone.
Guhlmann A; Keppler A; Kästner S; Krieter H; Brückner UB; Messmer K; Keppler D
J Exp Med; 1989 Dec; 170(6):1905-18. PubMed ID: 2584929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
